CASI Annual Current Liabilities
$16.73 M
-$279.00 K-1.64%
31 December 2023
Summary:
As of January 20, 2025, CASI annual total current liabilities is $16.73 million, with the most recent change of -$279.00 thousand (-1.64%) on December 31, 2023. During the last 3 years, it has risen by +$8.75 million (+109.70%). CASI annual current liabilities is now -19.33% below its all-time high of $20.73 million, reached on December 31, 2001.CASI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Quarterly Current Liabilities
$14.74 M
+$5.16 M+53.80%
01 September 2024
Summary:
As of January 20, 2025, CASI quarterly total current liabilities is $14.74 million, with the most recent change of +$5.16 million (+53.80%) on September 1, 2024. Over the past year, it has dropped by -$1.99 million (-11.88%). CASI quarterly current liabilities is now -50.46% below its all-time high of $29.75 million, reached on September 30, 2022.CASI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.6% | -11.9% |
| 3 y3 years | +109.7% | -11.9% |
| 5 y5 years | +331.9% | -11.9% |
CASI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.6% | +26.9% | -50.5% | +72.5% |
| 5 y | 5-year | -1.6% | +110.5% | -50.5% | +252.7% |
| alltime | all time | -19.3% | +2859.3% | -50.5% | +2839.6% |
CASI Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.74 M(+53.8%) |
| June 2024 | - | $9.58 M(+12.2%) |
| Mar 2024 | - | $8.54 M(-48.9%) |
| Dec 2023 | $16.73 M(-1.6%) | $16.73 M(+41.4%) |
| Sept 2023 | - | $11.83 M(-0.7%) |
| June 2023 | - | $11.91 M(-15.2%) |
| Mar 2023 | - | $14.04 M(-17.5%) |
| Dec 2022 | $17.00 M(+29.0%) | $17.00 M(-42.8%) |
| Sept 2022 | - | $29.75 M(+125.8%) |
| June 2022 | - | $13.18 M(-5.0%) |
| Mar 2022 | - | $13.87 M(+5.2%) |
| Dec 2021 | $13.19 M(+65.3%) | $13.19 M(+32.4%) |
| Sept 2021 | - | $9.96 M(-0.6%) |
| June 2021 | - | $10.02 M(+0.5%) |
| Mar 2021 | - | $9.97 M(+25.0%) |
| Dec 2020 | $7.98 M(+0.4%) | $7.98 M(+43.6%) |
| Sept 2020 | - | $5.55 M(+32.9%) |
| June 2020 | - | $4.18 M(-44.6%) |
| Mar 2020 | - | $7.54 M(-5.1%) |
| Dec 2019 | $7.95 M(+105.2%) | $7.95 M(+14.4%) |
| Sept 2019 | - | $6.95 M(+12.4%) |
| June 2019 | - | $6.18 M(+23.6%) |
| Mar 2019 | - | $5.00 M(+29.2%) |
| Dec 2018 | $3.87 M(-23.5%) | $3.87 M(-44.0%) |
| Sept 2018 | - | $6.92 M(+162.7%) |
| June 2018 | - | $2.63 M(+28.9%) |
| Mar 2018 | - | $2.04 M(-59.6%) |
| Dec 2017 | $5.06 M(+284.8%) | $5.06 M(+68.5%) |
| Sept 2017 | - | $3.00 M(+0.5%) |
| June 2017 | - | $2.99 M(+6.2%) |
| Mar 2017 | - | $2.81 M(+113.8%) |
| Dec 2016 | $1.32 M(+24.9%) | $1.32 M(-48.7%) |
| Sept 2016 | - | $2.57 M(-0.7%) |
| June 2016 | - | $2.59 M(+7.1%) |
| Mar 2016 | - | $2.41 M(+129.1%) |
| Dec 2015 | $1.05 M(+14.6%) | $1.05 M(+8.5%) |
| Sept 2015 | - | $971.00 K(-62.5%) |
| June 2015 | - | $2.59 M(+0.1%) |
| Mar 2015 | - | $2.58 M(+181.1%) |
| Dec 2014 | $919.00 K(+62.6%) | $919.00 K(+20.3%) |
| Sept 2014 | - | $764.20 K(+2.8%) |
| June 2014 | - | $743.30 K(-1.7%) |
| Mar 2014 | - | $755.90 K(+33.7%) |
| Dec 2013 | $565.20 K(-23.9%) | $565.20 K(+12.7%) |
| Sept 2013 | - | $501.40 K(-33.1%) |
| June 2013 | - | $749.70 K(-5.7%) |
| Mar 2013 | - | $794.60 K(+7.0%) |
| Dec 2012 | $742.80 K(+5.5%) | $742.80 K(+2.3%) |
| Sept 2012 | - | $726.10 K(-23.1%) |
| June 2012 | - | $944.80 K(-90.1%) |
| Mar 2012 | - | $9.58 M(+1260.9%) |
| Dec 2011 | $704.10 K(-74.0%) | $704.10 K(-7.4%) |
| Sept 2011 | - | $760.30 K(-40.7%) |
| June 2011 | - | $1.28 M(-25.2%) |
| Mar 2011 | - | $1.71 M(-36.7%) |
| Dec 2010 | $2.70 M | $2.70 M(-41.4%) |
| Sept 2010 | - | $4.61 M(-31.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | $6.73 M(-26.9%) |
| Mar 2010 | - | $9.20 M(-18.3%) |
| Dec 2009 | $11.27 M(-18.4%) | $11.27 M(+0.4%) |
| Sept 2009 | - | $11.22 M(+2.0%) |
| June 2009 | - | $11.00 M(-5.9%) |
| Mar 2009 | - | $11.70 M(-15.3%) |
| Dec 2008 | $13.81 M(+48.0%) | $13.81 M(+5.1%) |
| Sept 2008 | - | $13.14 M(+3.2%) |
| June 2008 | - | $12.74 M(+15.4%) |
| Mar 2008 | - | $11.04 M(+18.3%) |
| Dec 2007 | $9.33 M(+8.3%) | $9.33 M(+25.9%) |
| Sept 2007 | - | $7.41 M(+6.2%) |
| June 2007 | - | $6.98 M(-8.3%) |
| Mar 2007 | - | $7.61 M(-11.7%) |
| Dec 2006 | $8.62 M(+26.4%) | $8.62 M(+16.9%) |
| Sept 2006 | - | $7.37 M(+14.6%) |
| June 2006 | - | $6.44 M(+8.0%) |
| Mar 2006 | - | $5.96 M(-12.6%) |
| Dec 2005 | $6.82 M(+108.9%) | $6.82 M(+56.2%) |
| Sept 2005 | - | $4.36 M(+52.4%) |
| June 2005 | - | $2.86 M(-40.0%) |
| Mar 2005 | - | $4.77 M(+46.2%) |
| Dec 2004 | $3.26 M(-31.4%) | $3.26 M(+60.6%) |
| Sept 2004 | - | $2.03 M(-5.9%) |
| June 2004 | - | $2.16 M(-20.0%) |
| Mar 2004 | - | $2.70 M(-43.3%) |
| Dec 2003 | $4.75 M(-71.9%) | $4.75 M(+68.4%) |
| Sept 2003 | - | $2.82 M(+0.3%) |
| June 2003 | - | $2.82 M(-51.8%) |
| Mar 2003 | - | $5.84 M(-65.5%) |
| Dec 2002 | $16.93 M(-18.3%) | $16.93 M(+16.1%) |
| Sept 2002 | - | $14.58 M(+68.0%) |
| June 2002 | - | $8.68 M(-35.9%) |
| Mar 2002 | - | $13.54 M(-34.7%) |
| Dec 2001 | $20.73 M(+82.7%) | $20.73 M(+15.3%) |
| Sept 2001 | - | $17.97 M(+36.1%) |
| June 2001 | - | $13.20 M(+18.7%) |
| Mar 2001 | - | $11.12 M(-2.0%) |
| Dec 2000 | $11.35 M(+44.6%) | $11.35 M(+55.6%) |
| Sept 2000 | - | $7.29 M(-0.7%) |
| June 2000 | - | $7.34 M(+33.0%) |
| Mar 2000 | - | $5.52 M(-29.6%) |
| Dec 1999 | $7.84 M(+22.6%) | $7.84 M(+48.0%) |
| Sept 1999 | - | $5.30 M(-11.7%) |
| June 1999 | - | $6.00 M(-4.8%) |
| Mar 1999 | - | $6.30 M(-1.6%) |
| Dec 1998 | $6.40 M(+42.2%) | $6.40 M(+68.4%) |
| Sept 1998 | - | $3.80 M(-7.3%) |
| June 1998 | - | $4.10 M(+13.9%) |
| Mar 1998 | - | $3.60 M(-20.0%) |
| Dec 1997 | $4.50 M(+7.1%) | $4.50 M(+80.0%) |
| Sept 1997 | - | $2.50 M(-34.2%) |
| June 1997 | - | $3.80 M(+18.8%) |
| Mar 1997 | - | $3.20 M(-23.8%) |
| Dec 1996 | $4.20 M | $4.20 M(+16.7%) |
| Sept 1996 | - | $3.60 M(-14.3%) |
| June 1996 | - | $4.20 M(+5.0%) |
| Mar 1996 | - | $4.00 M |
FAQ
- What is CASI Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual current liabilities year-on-year change?
- What is CASI Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly current liabilities year-on-year change?
What is CASI Pharmaceuticals annual total current liabilities?
The current annual current liabilities of CASI is $16.73 M
What is the all time high annual current liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual total current liabilities is $20.73 M
What is CASI Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, CASI annual total current liabilities has changed by -$279.00 K (-1.64%)
What is CASI Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of CASI is $14.74 M
What is the all time high quarterly current liabilities for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly total current liabilities is $29.75 M
What is CASI Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, CASI quarterly total current liabilities has changed by -$1.99 M (-11.88%)